# Abdominal aBscess Catheter Sclerotherapy (ABCS)

> **NCT06906029** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Alabama at Birmingham** · enrollment: 60 (estimated)

## Conditions studied

- Abdominal Abscess

## Interventions

- **DRUG:** Catheter Sclerotherapy

## Key facts

- **NCT ID:** NCT06906029
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-07
- **Final completion:** 2028-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06906029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06906029, "Abdominal aBscess Catheter Sclerotherapy (ABCS)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06906029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*